
Alignment Healthcare (ALHC) Stock Forecast & Price Target
Alignment Healthcare (ALHC) Analyst Ratings
Bulls say
Alignment Healthcare Inc. is strategically positioned to capitalize on the anticipated favorable 2026 Medicare Advantage rate update, especially as many competing Managed Care Organizations are reducing benefits. The company's integrated Medicare Advantage and Value-Based Care model is expected to facilitate long-term market share growth and above-average financial performance. Additionally, projections indicate robust growth in gross profit per member per month (PMPM), with initial cohorts generating $90-$150 PMPM, potentially increasing to over $230 PMPM in subsequent years, further supporting a positive financial outlook.
Bears say
Alignment Healthcare Inc has demonstrated a reduction in average daily kickouts (ADK) during a period of increased healthcare utilization, highlighting the strength of its technology and operating model. However, the company's approach to value-based care (VBC) faces challenges, such as data friction among various payors and difficulty in achieving consistent outcomes with affiliated primary care providers (PCPs). Additionally, despite reporting above-average EBITDA growth, the valuation multiples for Alignment Healthcare remain elevated compared to peers, which may suggest potential overvaluation concerns amidst these operational challenges.
This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Alignment Healthcare (ALHC) Analyst Forecast & Price Prediction
Start investing in Alignment Healthcare (ALHC)
Order type
Buy in
Order amount
Est. shares
0 shares